Eileen Marshall’s practice includes all aspects of domestic and cross-border mergers, acquisitions, divestitures, restructurings, tax-free reorganizations, taxable and tax-free spinoffs, incorporations, and partnership formations. She also has significant experience advising on tax issues in connection with public and private equity and debt financings and restructurings.
IAA’s Acquisition by Ritchie Bros. Closes Following Shareholder Approval
March 23, 2023
Cooley advised IAA, Inc. (IAA), a global digital marketplace connecting vehicle buyers and sellers, on its cross-border stock and cash acquisition by Ritchie Bros., which closed on Monday, March 20.
Pie Insurance Announces $315 Million Series D Funding Round
February 1, 2023
Cooley advised Pie Insurance, an insurtech company focused on providing workers’ compensation insurance for small businesses, on its $315 million Series D financing round, which brings the company’s total equity funding raised to more than $615 million.
Amryt Pharma to Sell to Chiesi Farmaceutici in $1.48 Billion Cross-Border Transaction
January 9, 2023
Cooley advised Amryt Pharma, a Dublin, Ireland-based commercial-stage biopharmaceutical company, on its definitive agreement to be acquired by Chiesi Farmaceutici, a Parma, Italy-based research-focused biopharmaceuticals and healthcare group, in a $1.48 billion cash and contingent value right (CVR) transaction. Partners Bill Sorabella, Claire Keast-Butler and Bill Roegge led the joint US and UK Cooley team advising Amryt.
Cooley advised Oyster Point Pharma, a top ophthalmology-focused biopharmaceutical company, on its definitive agreement to be acquired by global healthcare company Viatris. Partners Mika Reiner Mayer, Brandon Fenn, Div Gupta and Ian Nussbaum led the Cooley team advising Oyster Point Pharma.